GSAM Fundamental Equity Update: Japan Exposure Talking Points

In light of recent events, we would like to update you on the Fundamental Equity Team’s exposure to Japan across our global platform as of March 16, 2011.

The Global, International and International Small Cap Equity portfolios all have relatively neutral direct exposure to Japan vis-à-vis their benchmarks, as we take the majority of our risk through bottom-up stock selection rather than through deviations at the country level. Our European Equity portfolios have no direct exposure to Japan. Indirect exposure to Japan in these portfolios is largely stock-specific and, in general, limited to the following sectors: Insurance, Energy, Utilities, Information Technology, Industrials, Materials, Health Care and Luxury Goods.

The US Value, US Growth, and US Equity portfolios have minimal exposure to Japan driven by the nature of our US orientation. We expect even less of an impact to our smaller cap US portfolios. Overall, we have not made any major changes or sector shifts as a result of the crisis in Japan, but we are monitoring certain individual securities carefully. The indirect exposure is stock specific and largely isolated to the following sectors:

• Value: Insurance, Industrials, Information Technology, Utilities, Materials, Consumer Discretionary
• Growth: Information Technology, Health Care, Industrials
• US Equity: Information Technology, Industrials, Insurance and Health Care

In Asia, we believe the impact will be to property companies with assets in Japan, refineries and petrochemical sectors, and coal. We believe rebuilding in Japan is also likely to spur demand for building materials. We continue to closely monitor our portfolios’ positioning.
 

Summary prospectuses, or Prospectus for the Fund containing more information may be obtained from your investment professional or from Goldman, Sachs & Co. by calling 1-800-526-7384. Please consider the Fund’s objectives, risks, and charges and expenses, and read the Prospectus or Summary Prospectus carefully before investing. They contain this and other information about the Funds.
 

_{Opinions expressed are current opinions as of the date appearing in this material only. No part of this material may, without GSAM’s prior written consent, be (i) copied, photocopied or duplicated in any form, by any means, or (ii) distributed to any person that is not an employee, officer, director, or authorized agent of the recipient.}

_{The Global Industry Classification Standard (GICS) was developed by and is the exclusive property and a service mark of Morgan Stanley Capital International Inc. (MSCI) and Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. (S&P) and is licensed for use by Goldman Sachs. Neither MSCI, S&P nor any other party involved in making or compiling the GICS or any GICS classifications makes any express or implied warranties or representations with respect to such standard or classification (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such standard or classification. Without limiting any of the foregoing, in no event shall MSCI, S&P, any of their affiliates or any third party involved in making or compiling the GICS or any GICS classifications have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.
Goldman, Sachs & Co. is the distributor of the Goldman Sachs Funds.}

_{© 2011 Goldman Sachs. All rights reserved. Date of first use: March 25, 2011. 49895.MF.MED.OTU
NOT FDIC-INSURED                              May Lose Value                              No Bank Guarantee}